30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Amelanotic Melanoma in the Vicinity of Acquired Melanocytic Nevi and not Arising from Agminated Melanocytic Nevi: Masquerading as Pyogenic Granuloma

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Amelanotic melanoma (AMM) presenting as pyogenic granuloma and occurring in the vicinity of acquired melanocytic nevi is rare. Herein, we report such a manifestation in a 68-year-old male who presented with the painful red nodule and multiple pigmented patches involving the left great toe. Histopathological examination of skin biopsy taken from the nodule with an immunohistochemical study using HMB45 and S-100 confirmed the diagnosis of AMM. Biopsy from the pigmented patch near the nodule showed features of melanocytic nevus. Investigative work up revealed metastatic deposits in the left inguinal lymph node with no evidence of systemic involvement, placing him in malignant melanoma Stage IIIC of American Joint Committee on Cancer (AJCC) tumor node metastasis system. The development of AMM in the vicinity of acquired melanocytic nevi and manifesting as granuloma pyogenicum is unique in this case.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: not found
          • Article: not found

          Melanoma.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            BRAF(E600) in benign and malignant human tumours.

            Of the RAF family of protein kinases, BRAF is the only member to be frequently activated by mutation in cancer. A single amino acid substitution (V600E) accounts for the vast majority and results in constitutive activation of BRAF kinase function. Its expression is required to maintain the proliferative and oncogenic characteristics of BRAF(E600)-expressing human tumour cells. Although BRAF(E600) acts as an oncogene in the context of additional genetic lesions, in primary cells it appears to be associated rather with transient stimulation of proliferation. Eventually, BRAF(E600) signalling triggers cell cycle arrest with the hallmarks of cellular senescence, as is illustrated by several recent studies in cultured cells, animal models and benign human lesions. In this review, we will discuss recent advances in our understanding of the role of BRAF(E600) in benign and malignant human tumours and the implications for therapeutic intervention.
              Bookmark
              • Record: found
              • Abstract: not found
              • Book: not found

              Histopathology of the skin

                Bookmark

                Author and article information

                Journal
                Indian J Dermatol
                Indian J Dermatol
                IJD
                Indian Journal of Dermatology
                Medknow Publications & Media Pvt Ltd (India )
                0019-5154
                1998-3611
                Jan-Feb 2016
                : 61
                : 1
                : 122
                Affiliations
                [1] From the Department of Dermatology, SVS Medical College, Yenugonda, Mahbubnagar, Telangana, India
                Author notes
                Address for correspondence: Prof. Angoori Gnaneshwar Rao, F12, B8, HIG-2 APHB, Baghlingampally, Hyderabad - 500 044, Telangana, India. E-mail: dr_a_g_rao@ 123456yahoo.co.in
                Article
                IJD-61-122c
                10.4103/0019-5154.174135
                4763653
                26955141
                be90d0f1-e1b9-46a0-86d8-737406cba281
                Copyright: © Indian Journal of Dermatology

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

                History
                : January 2015
                : July 2015
                Categories
                E-IJD Case Report

                Dermatology
                amelanotic melanoma,hmb45,melanocytic nevi immunohistochemistry,pyogenic granuloma,s-100

                Comments

                Comment on this article